Search clinical trials for: Drug Utilization Review

Total 262058 results

Eastern Cooperative Oncology Group
National Cancer Institute (NCI)

Completed

Dasatinib in Treating Patients With Locally Advanced or Metastatic Mucosal Melanoma, Acral Melanoma, or Vulvovaginal Melanoma That Cannot Be Removed By Surgery

Melanoma (Skin)

United States
Eastern Cooperative Oncology Group

Terminated

Rituximab and Combination Chemotherapy in Treating Patients With Primary Central Nervous System Lymphoma

Lymphoma

United States
ECOG-ACRIN Cancer Research Group
National Cancer Institute (NCI)

Completed

Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer

Breast Cancer | Stage IV Breast Cancer

United States, Canada, Peru
Eastern Cooperative Oncology Group
National Cancer Institute (NCI)

Terminated

Rituximab and Combination Chemotherapy in Treating Patients With Newly Diagnosed Waldenstrom's Macroglobulinemia

Lymphoma

United States
Eastern Cooperative Oncology Group
National Cancer Institute (NCI)

Completed

Pentostatin, Cyclophosphamide, and Rituximab Followed By Campath-1H in Patients With Relapsed or Refractory B-Cell CLL

Leukemia

United States
Eastern Cooperative Oncology Group
National Cancer Institute (NCI)

Completed

Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma

Lymphoma

United States, Canada, South Africa
Sykehuset i Vestfold HF
Hospital Pharmacy Enterprise, South Eastern Norway

Completed

Patient Pathway Pharmacist - Optimal Drug-related Care

Aging | Hip Fractures | Patient Fall

Norway
ECOG-ACRIN Cancer Research Group
National Cancer Institute (NCI)

Completed

Cetuximab, Cisplatin, Fluorouracil, and Radiation Therapy in Treating Patients With Anal Cancer

Anal Cancer

United States
Eastern Cooperative Oncology Group
National Cancer Institute (NCI)

Completed

Irinotecan Hydrochloride and Cetuximab With or Without Ramucirumab in Treating Patients With Advanced Colorectal Cancer With Progressive Disease After Treatment With Bevacizumab-Containing Chemotherapy

Colorectal Cancer

United States
Eastern Cooperative Oncology Group
National Cancer Institute (NCI)

Completed

Cetuximab in Treating Patients With Recurrent or Stage IIIB or Stage IV Lung Cancer

Lung Cancer

United States
ECOG-ACRIN Cancer Research Group
National Cancer Institute (NCI); NCIC Clinical Trials Group; Children's Oncology... and other collaborators

Active, not recruiting

High-Dose Interferon Alfa in Treating Patients With Stage II or Stage III Melanoma

Melanoma (Skin)

United States, Canada, Australia, South Africa
Eastern Cooperative Oncology Group
National Cancer Institute (NCI)

Completed

Induction Chemotherapy Followed By Cetuximab and Radiation in HPV-Associated Resectable Stage III/IV Oropharynx Cancer

Head and Neck Cancer | Precancerous Condition

United States
NantBioScience, Inc.

Active, not recruiting

QUILT-2.025 NANT Neoepitope Yeast Vaccine (YE-NEO-001): Adjuvant Immunotherapy Using a Personalized Neoepitope Yeast-Based Vaccine To Induce T-Cell Responses In Subjects W/ Previously Treated Cancers.

Melanoma | Breast Cancer | Colorectal Cancer | Pancreatic Cancer | Non Small Cell Lung Cancer | Head and Neck Squamous Cell Carcinoma | Liver Cancer

United States
University of Virginia

Completed

Impact of Functional Status on 30-day Resource Utilization and Organ System Complications Following Bariatric Surgery

Frailty | Perioperative/Postoperative Complications | Dependence
Damanhour University

Completed

Ciprofloxacin Utilization and Adverse Events Occurrence in Community Pharmacy Setting

Ciprofloxacin Adverse Reaction

Egypt
Eastern Cooperative Oncology Group
National Cancer Institute (NCI)

Completed

Bevacizumab and Combination Chemotherapy in Treating Patients With Peripheral T-Cell Lymphoma or Natural Killer Cell Neoplasms

Lymphoma

United States
Eastern Cooperative Oncology Group
National Cancer Institute (NCI)

Completed

Chemotherapy and Radiation Therapy in Treating Patients With Stage III or Stage IV Larynx or Oropharynx Cancer

Head and Neck Cancer

United States
Eastern Cooperative Oncology Group
National Cancer Institute (NCI); NCIC Clinical Trials Group

Completed

Quality of Life in Postmenopausal Women Who Are Receiving Either Exemestane or Anastrozole With or Without Celecoxib for Stage I, Stage II, or Stage IIIA Primary Breast Cancer

Breast Cancer

United States
Eastern Cooperative Oncology Group
National Cancer Institute (NCI)

Completed

Epoetin Alfa With or Without Dexamethasone in Treating Fatigue and Anemia in Patients With Hormone-Refractory Prostate Cancer

Fatigue | Anemia | Prostate Cancer

United States
ECOG-ACRIN Cancer Research Group
National Cancer Institute (NCI)

Completed

Sunitinib Malate With or Without Gemcitabine Hydrochloride in Treating Patients With Advanced Kidney Cancer That Cannot Be Removed By Surgery

Kidney Cancer

United States
Pfizer

Completed

Apixaban Drug Utilization Study In Stroke Prevention In Atrial Fibrillation (Spaf) (SPAF)

Atrial Fibrillation

Spain
Tor Biering-Sørensen
Sanofi Pasteur, a Sanofi Company; Statens Serum Institut

Completed

Nationwide Utilization of Danish Government Electronic Letter System for Increasing InFLUenza Vaccine Uptake (NUDGE-FLU)

Influenza | Behavior and Behavior Mechanisms

Denmark
Corcept Therapeutics

Completed

Retrospective Chart Review Study of Korlym for the Treatment of ACTH Independent Cushing's Syndrome (RE-KLAIM)

Cushing's Syndrome
Rockefeller University
Weill Medical College of Cornell University

Terminated

Exploratory Study of Melatonin Induced Sleep Regularization in Severe Brain Injury

Disorders of Consciousness

United States
Brown University
Boston University; Rhode Island Hospital; National Institute of General Medical... and other collaborators

Completed

CoMBAT Opioid Use Disorder: A Combined Medication and Behavioral Activation Treatment for People Living With Opioid Use Disorder (CoMBAT_OUD)

Medication Adherence | Opioid-use Disorder | Health Care Utilization

United States
Novartis Pharmaceuticals

Completed

Retrospective Assessment of AE-Related Healthcare Resource Utilization and Costs of Immune Checkpoint Inhibitor and Targeted Therapy for Adjuvant Treatment of Melanoma

Melanoma

United States
Eli Lilly and Company
Dermira, Inc.

Completed

Evaluation of the Efficacy and Safety of Lebrikizumab (LY3650150) in Moderate to Severe Atopic Dermatitis (ADvocate2)

Atopic Dermatitis

United States, Canada, Taiwan, Singapore, Germany, Bulgaria, Ukraine, Mexico
University of Massachusetts, Worcester
National Institute on Aging (NIA); University of Utah; Boston College

Active, not recruiting

Standardized Patient-Centered Medication Review in Home Hospice (SPECTORx)

Palliative Care | Interdisciplinary Communication | Caregivers | Deprescriptions | Hospices | Poly Pharmacy | Prescription Drug Overuse

United States
Northwestern University

Completed

Excimer Laser Assisted IVC Filter Retrieval

IVC Filters

United States
Novartis Pharmaceuticals

Terminated

Healthcare Resource Utilization and Costs in Metastatic Melanoma Patients Initiated Dabrafenib + Trametinib and Encorafenib + Binimetinib

Metastatic Melanoma

United States
VA Boston Healthcare System

Enrolling by invitation

De-Implementation of Inappropriate Antimicrobial Use After Cardiac Device Procedures (CIED)

Antibiotics Causing Adverse Effects in Therapeutic Use

United States
Nottingham University Hospitals NHS Trust
University of Nottingham

Completed

Exploring Efficacy, Cost Effectiveness and Experiences Related to Adherence of Different Bisphosphonate Regimens for the Prevention of Osteoporotic Fragility Fractures. (BLASTOFF)

Osteoporosis

United Kingdom
Seoul National University Hospital

Completed

Acalabrutinib With Rituximab and Lenalidomide in Relapsed/Refractory B-cell Non-Hodgkin Lymphoma

Non-hodgkin Lymphoma,B Cell

Korea, Republic of
Takeda

Completed

A Study Reviewing Medical Records of Adults With Helicobacter Pylori Infections in China

Helicobacter Pylori

China
Kyowa Kirin Pharmaceutical Development Ltd

Completed

Naloxegol Drug Utilization Post Authorisation Safety Study

Opioid Induced Constipation

United Kingdom, Norway, Sweden, Germany
Novartis Pharmaceuticals

Completed

Retrospective Chart Review and Historical Comparison of Capmatinib vs. Standard of Care for German Adult Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) Harboring METex14 Mutations (RECAP)

Locally Advanced or Metastatic Non-Small Cell Lung Cancer Harboring METex14 Mutations

Germany
Translational Drug Development
Side-Out Foundation

Completed

A Pilot Study Utilizing Proteomic and Genomic Profiling for Patients With Metastatic Breast Cancer (SO2)

Metastatic Breast Cancer

United States
Median Technologies

Completed

BICR in New Therapeutic Lung Cancer Trials

Lung Cancer

France
Hawassa University
EngenderHealth

Completed

EPI, a Missed Opportunity for Postpartum Family Planning Utilization (EPI)

Contraception

Ethiopia
AstraZeneca

Completed

A Study of Verinurad and Allopurinol in Patients With Chronic Kidney Disease and Hyperuricaemia (SAPPHIRE)

Chronic Kidney Disease

United States, Italy, Spain, France, Czechia, Israel, Slovakia, South Africa, Hungary, Poland, Mexico, Romania
Takeda

Completed

A Chart Review Study of Adults With Advanced NSCLC (EXTRACT)

Non-small Cell Lung Cancer (NSCLC)

Hong Kong, France, Canada
Timothy Hoffman
University of Missouri-Columbia; Harry S. Truman Memorial Veterans' Hospital; Telix Pharmaceuticals, Ltd

Terminated

Ga-68-PSMA-11 in Men With Prostate Cancer (Ga68-PSMA-11)

Prostate Cancer | Prostate Adenocarcinoma

United States
Assistance Publique - Hôpitaux de Paris
Agence Nationale de Recherche (ANR) National Research Agency

Completed

Impact of the COVID-19 Pandemic on Mental Health Service Utilization in Children and Adolescents (MENTALPED)

Mental Disorder, Child

France
Diakonhjemmet Hospital
University of Oslo; Diakonhjemmet Hospital Pharmacy; Diakonhjemmet Foundation

Completed

Improving Drug Safety in Emergency Patients -a Randomized Controlled Trial (EPIMERR)

Drug-Related Side Effects and Adverse Reactions | Drug Interaction Potentiation | Medication Compliance | Remission | Medicinal Substance; Adverse Effect

Norway
Aurora Health Care
Chitogen, Inc.

Completed

RAVE: Radial Artery Vascular Complication and Resource Utilization

Percutaneous Coronary Intervention | Angiogram

United States
Imperial College London
University of Aberdeen

Completed

Metastatic Prostate Cancer Men's Attitudes Towards Treatment of the Local Tumour and Metastasis Evaluative Research (IP5-MATTER)

Quality of Life | Surgery | Patient Satisfaction | Health Care Utilization | Prostate Cancer Metastatic | Radiotherapy Side Effect | Urologic Cancer

United Kingdom
Novartis Pharmaceuticals

Completed

Retrospective Assessment of Adverse Events-related Healthcare Resource Utilization and Costs of Immune Checkpoint Inhibitor and Targeted Therapy for Adjuvant Treatment of Melanoma

Melanoma

United States
Eli Lilly and Company

Completed

A Study of Ramucirumab (LY3009806) Versus Placebo in Participants With Hepatocellular Carcinoma and Elevated Baseline Alpha-Fetoprotein (REACH-2)

Hepatocellular Carcinoma

Italy, United States, Spain, China, Korea, Republic of, Taiwan, France, Japan, Germany, Belgium, Austria, Brazil, Czechia, Canada, Poland, United Kingdom, Israel, Australia, Hong Kong, Switzerland
Hospices Civils de Lyon

Completed

Observe Alternating Hemiplegia of Childhood (OBSERV-AHC) Study (OBSERV-AHC)

Alternating Hemiplegia

France
Southwest Oncology Group
National Cancer Institute (NCI)

Completed

S0521, Combination Chemotherapy With or Without Gemtuzumab Followed By Tretinoin, Mercaptopurine, and Methotrexate or Observation in Treating Patients With Acute Promyelocytic Leukemia

Leukemia

United States

Search clinical trials for: Drug Utilization Review

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in United States

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations